- Home
- LNTH vs EXLS Comparison
LNTH vs EXLS Comparison
Compare LNTH & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | EXLS |
|---|---|---|
| Founded | 1956 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 6.6B |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | LNTH | EXLS |
|---|---|---|
| Price | $65.24 | $42.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $77.67 | $54.50 |
| AVG Volume (30 Days) | ★ 1.1M | 1.1M |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.94 |
| EPS | ★ 2.39 | 1.48 |
| Revenue | $1,525,933,000.00 | ★ $2,026,490,000.00 |
| Revenue This Year | $0.01 | $15.27 |
| Revenue Next Year | $1.24 | $11.33 |
| P/E Ratio | ★ $27.26 | $28.67 |
| Revenue Growth | 1.95 | ★ 14.43 |
| 52 Week Low | $47.25 | $37.30 |
| 52 Week High | $111.29 | $52.43 |
Technical Indicators
Market Signals| Indicator | LNTH | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 67.79 | 67.10 |
| Support Level | $64.84 | $41.00 |
| Resistance Level | $67.01 | $42.03 |
| Average True Range (ATR) | 2.02 | 0.74 |
| MACD | 0.44 | 0.28 |
| Stochastic Oscillator | 84.18 | 96.33 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.